CUAMC
GBIO

China Universal Asset Management Company’s Generation Bio GBIO Stock Holding History

China Universal Asset Management Company’s Portfolio GBIO Stock Details GBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-170
Closed -$6.42K – 449
2023
Q3 		$6.42K Buy
170
+84
+98% +$3.98K ﹤0.01% 373
2023
Q2 		$4.74K Buy
86
+5
+6% +$229 ﹤0.01% 374
2023
Q1 		$3.47K Buy
81
+21
+35% +$1.02K ﹤0.01% 405
2022
Q4 		$2.37K Buy
60
+5
+9% +$263 ﹤0.01% 360
2022
Q3 		$3K Buy
+55
New +$3.44K ﹤0.01% 324

Other funds holding GBIO

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

China Universal Asset Management Company's GBIO Position: Q4 2023 in Review

China Universal Asset Management Company sold out of Generation Bio (GBIO) in Q4 2023, closing a stake of 170 shares — an estimated $6.42K sold.

China Universal Asset Management Company first reported a position in GBIO in Q3 2022 and held it in 5 quarters. The position peaked at $6.42K in Q3 2023. 74 funds tracked by Wall St. Rank hold GBIO as of Q4 2023.

  • China Universal Asset Management Company reported no remaining Generation Bio position as of Q4 2023 after selling out during the quarter.
  • China Universal Asset Management Company sold 170 Generation Bio shares in Q4 2023, an estimated $6.42K.
  • China Universal Asset Management Company first reported a position in Generation Bio in Q3 2022 and held it in 5 quarters.
  • China Universal Asset Management Company's Generation Bio position peaked at $6.42K in Q3 2023.
  • 74 funds tracked by Wall St. Rank held Generation Bio as of Q4 2023.

Based on China Universal Asset Management Company's 13F filing for Q4 2023, filed 24 Jan 2024.